New hope for breast cancer patients as life-extending drug now on NHS in England

Patients in England with a specific type of incurable breast cancer can now access the life-extending drug Enhertu on the NHS, two years after it was deemed too expensive. This treatment can give patients almost seven extra months to live on average, with some living up to three years longer. While women in Scotland have had access to the drug since 2023, this decision will affect about 1,000 women a year in England.